OPKO is a GOLD Sponsor for the 2024 Vitamin D Workshop. OPKO has been a strong supporter of the workshop for many years.  OPKO has developed RAYALDEE , an extended-release oral formulation of calcifediol which is approved by the FDA for treatment of secondary hyperparathyroidism in adults with CKD and vitamin D insufficiency. Please visit their website and network with their scientists during the meeting.